While completely disrupting ThymoD transcription impairs Bcl11b expression levels and leads to impaired T-cell development and consequently leukemia, removal of the TE only moderately delays Bcl11b activation by ∼3 days without affecting its maintenance and subsequent T-cell maturation and function once expressed. Here, BCL11B is linked to leukemia.